These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 27941529)
21. MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A COMPARATIVE STUDY OF EXUDATIVE AND NONEXUDATIVE FELLOW EYES. Gergely R; Kovács I; Schneider M; Resch M; Papp A; Récsán Z; Nagy ZZ; Ecsedy M Retina; 2017 Jun; 37(6):1084-1091. PubMed ID: 27627749 [TBL] [Abstract][Full Text] [Related]
22. DYSFUNCTIONAL AUTONOMIC REGULATION OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY. Nathaniel Roybal C; Sledz E; Elshatory Y; Zhang L; Almeida DRP; Chin EK; Critser B; Abramoff MD; Russell SR Retina; 2018 Jun; 38(6):1205-1210. PubMed ID: 28489693 [TBL] [Abstract][Full Text] [Related]
23. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy. Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850 [TBL] [Abstract][Full Text] [Related]
24. [Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy]. Li L; Li DH; Yang ZK; Bian AL; Chen YX; Dong FT Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):878-82. PubMed ID: 23302240 [TBL] [Abstract][Full Text] [Related]
25. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy. Pang CE; Shah VP; Sarraf D; Freund KB Am J Ophthalmol; 2014 Aug; 158(2):362-371.e2. PubMed ID: 24794091 [TBL] [Abstract][Full Text] [Related]
26. Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy. Munk MR; Shah R; Pappas F; Baddar D; Wong B; Jampol LM; Fawzi AA Curr Eye Res; 2016; 41(1):97-106. PubMed ID: 25612245 [TBL] [Abstract][Full Text] [Related]
27. Focal choroidal excavation in patients with central serous chorioretinopathy. Luk FO; Fok AC; Lee A; Liu AT; Lai TY; Eye (Lond); 2015 Apr; 29(4):453-9. PubMed ID: 25853402 [TBL] [Abstract][Full Text] [Related]
28. Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography. Nicolò M; Rosa R; Musetti D; Musolino M; Saccheggiani M; Traverso CE Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2002-2010. PubMed ID: 28384721 [TBL] [Abstract][Full Text] [Related]
29. Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy. An SH; Kwon YH Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1489-1496. PubMed ID: 26553195 [TBL] [Abstract][Full Text] [Related]
30. Choroidal thickness in central serous chorioretinopathy. Kuroda S; Ikuno Y; Yasuno Y; Nakai K; Usui S; Sawa M; Tsujikawa M; Gomi F; Nishida K Retina; 2013 Feb; 33(2):302-8. PubMed ID: 23064424 [TBL] [Abstract][Full Text] [Related]
31. SUBFOVEAL CHOROIDAL THICKNESS CHANGES IN TREATED IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY AND THEIR ASSOCIATION WITH RECURRENCE. Kim DY; Joe SG; Yang HS; Lee JY; Kim JG; Yoon YH Retina; 2015 Sep; 35(9):1867-74. PubMed ID: 25946693 [TBL] [Abstract][Full Text] [Related]
32. Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ooto S; Tsujikawa A; Mori S; Tamura H; Yamashiro K; Yoshimura N Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1077-86. PubMed ID: 20229103 [TBL] [Abstract][Full Text] [Related]
33. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy. Hamzah F; Shinojima A; Mori R; Yuzawa M BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855 [TBL] [Abstract][Full Text] [Related]
34. Does Subretinal Fluid Optical Density Ratio Differ Among the Eyes with Acute Central Serous Chorioretinopathy,Vogt Koyanagi Harada Disease and Choroidal Hemangioma: A Cross-sectional Study. Durmaz Engin C; Kayabasi M; Koksaldi S; Ipek SC; Saatci AO Photodiagnosis Photodyn Ther; 2023 Jun; 42():103634. PubMed ID: 37244453 [TBL] [Abstract][Full Text] [Related]
35. Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy. Manabe S; Shiragami C; Hirooka K; Izumibata S; Tsujikawa A; Shiraga F Am J Ophthalmol; 2015 Apr; 159(4):644-51. PubMed ID: 25595669 [TBL] [Abstract][Full Text] [Related]
36. [Minute granular lesions of the retinal pigment epithelium related to choroidal hyperpermeability in patients with central serous chorioretinopathy]. Takeda M; Sato Y Nippon Ganka Gakkai Zasshi; 2013 Jan; 117(1):44-9. PubMed ID: 23424975 [TBL] [Abstract][Full Text] [Related]
37. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy. Razavi S; Souied EH; Cavallero E; Weber M; Querques G Am J Ophthalmol; 2014 Apr; 157(4):852-60. PubMed ID: 24412124 [TBL] [Abstract][Full Text] [Related]
38. [Differential diagnostic OCT-criteria of acute and chronic central serous chorioretinopathy]. Doga AV; Klepinina OB; Pedanova EK; Mushkova IA Vestn Oftalmol; 2017; 133(6):10-15. PubMed ID: 29319664 [TBL] [Abstract][Full Text] [Related]
39. Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Saito M; Saito W; Hashimoto Y; Yoshizawa C; Fujiya A; Noda K; Ishida S Br J Ophthalmol; 2013 Jun; 97(6):775-80. PubMed ID: 23532615 [TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the choroid in central serous chorioretinopathy]. Maruko I Nippon Ganka Gakkai Zasshi; 2012 Nov; 116(11):1062-79. PubMed ID: 23316655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]